NIOX Group Plc (AIM:NIOX)
London
· Delayed Price · Currency is GBP · Price in GBX 70.20
-1.20 (-1.68%)
At close: Dec 5, 2025
NIOX Group Revenue
NIOX Group had revenue of 25.20M GBP in the half year ending June 30, 2025, with 34.04% growth. This brings the company's revenue in the last twelve months to 46.00M, up 21.37% year-over-year. In the year 2024, NIOX Group had annual revenue of 41.80M with 13.59% growth.
Revenue (ttm)
46.00M
Revenue Growth
+21.37%
P/S Ratio
6.38
Revenue / Employee
505.49K
Employees
91
Market Cap
293.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.80M | 5.00M | 13.59% |
| Dec 31, 2023 | 36.80M | 5.50M | 17.57% |
| Dec 31, 2022 | 31.30M | 3.40M | 12.19% |
| Dec 31, 2021 | 27.90M | 4.00M | 16.74% |
| Dec 31, 2020 | 23.90M | -10.70M | -30.92% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Convatec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Genus | 672.80M |
NIOX Group News
- 8 months ago - Private equity firm withdraws takeover bid for NIOX Group - This is Money
- 9 months ago - AIM Market Roundup: Priority Intelligence, Niox, Coral Products - The Armchair Trader